KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Clorox (CLX) over the last 16 years, with Q4 2025 value amounting to -$210.0 million.

  • Clorox's Cash from Financing Activities fell 9266.06% to -$210.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$847.0 million, marking a year-over-year increase of 557.41%. This contributed to the annual value of -$924.0 million for FY2025, which is 4106.87% down from last year.
  • As of Q4 2025, Clorox's Cash from Financing Activities stood at -$210.0 million, which was down 9266.06% from -$59.0 million recorded in Q3 2025.
  • Clorox's 5-year Cash from Financing Activities high stood at $155.0 million for Q3 2023, and its period low was -$447.0 million during Q2 2021.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$232.0 million (2023), whereas its average is -$207.8 million.
  • As far as peak fluctuations go, Clorox's Cash from Financing Activities crashed by 64545.45% in 2021, and later soared by 54285.71% in 2023.
  • Clorox's Cash from Financing Activities (Quarter) stood at -$143.0 million in 2021, then plummeted by 95.8% to -$280.0 million in 2022, then increased by 7.5% to -$259.0 million in 2023, then soared by 57.92% to -$109.0 million in 2024, then plummeted by 92.66% to -$210.0 million in 2025.
  • Its Cash from Financing Activities was -$210.0 million in Q4 2025, compared to -$59.0 million in Q3 2025 and -$279.0 million in Q2 2025.